Patient knowledge on reporting adverse drug reactions in Poland
Authors Staniszewska A, Dąbrowska-Bender M, Olejniczak D, Duda-Zalewska A, Bujalska-Zadrożny M
Received 19 July 2016
Accepted for publication 25 August 2016
Published 29 December 2016 Volume 2017:11 Pages 47—53
Checked for plagiarism Yes
Review by Single-blind
Peer reviewers approved by Dr Amy Norman
Peer reviewer comments 4
Editor who approved publication: Dr Johnny Chen
Anna Staniszewska,1 Marta Dąbrowska-Bender,2 Dominik Olejniczak,2 Aneta Duda-Zalewska,2 Magdalena Bujalska-Zadrożny3
1Department of Experimental and Clinical Pharmacology, 2Department of Public Health, 3Department of Pharmacodynamics, Medical University of Warsaw, Warsaw, Poland
Aim: The aim of the study was to assess patient knowledge on reporting of adverse drug reactions.
Materials and methods: A prospective study was conducted among 200 patients. The study was based on an original survey composed of 15 single- and multiple-choice questions. The study involved individuals who have experienced adverse reactions as well as individuals who have never experienced any adverse reactions; people over the age of 18; literate; residing in Mazowieckie Voivodeship, who have not been diagnosed with any disease that could compromise their logical thinking skills.
Results: The respondents who lived in the city had a greater knowledge compared to the respondents who lived in the countryside (Pearson’s χ2=47.70, P=0.0013). The respondents who lived in the city were also more statistically likely to provide a correct answer to the question about the type of adverse reactions to be reported (Pearson’s χ2=50.66, P=0.012). Statistically significant associations were found between the place of residence of the respondents and the correct answer to the question about the data that must be included in the report on adverse reactions (Pearson’s χ2=11.7, P<0.0001).
Keywords: adverse reactions, medicinal products, pharmacovigilance, Mazowieckie Voivodeship
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]